Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 2c, Offers FY19 and FY20 Guidance

November 12, 2019 4:41 PM

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 EPS of $0.13, $0.02 better than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found